Vector-borne diseases (VBDs) present a significant public health challenge, particularly in tropical regions like India. This article seeks to enhance understanding of the complexity of VBDs in India, offering crucial insights for healthcare professionals.
India is disproportionately affected by VBDs due to its diverse ecological settings conducive for the proliferation of vectors. Diseases like malaria, dengue, and chikungunya are endemic, causing significant morbidity and mortality. The country's vast population and socio-economic disparities further exacerbate the situation.
VBDs in India are complex due to multi-dimensional factors. These include biological factors such as vector and pathogen diversity, and environmental factors like climate change and urbanization. Socio-economic factors like poverty, lack of sanitation, and inadequate healthcare infrastructure also contribute to this complexity.
Vector control in India faces numerous challenges. The vast geographical diversity necessitates region-specific strategies. Additionally, factors like insecticide resistance, lack of public awareness, and inadequate surveillance systems hinder effective control measures. The increasing trend of urbanization and climate change also complicate vector control efforts.
Healthcare professionals play a pivotal role in managing VBDs. Their responsibilities span from clinical management of cases to public health advocacy. They are instrumental in improving disease surveillance, promoting preventive measures, and contributing to policy-making for VBD control.
Understanding the complexity of VBDs in India is crucial for healthcare professionals. It aids in formulating effective strategies for disease control and prevention. Continuous research, inter-sectoral collaboration, and capacity building of healthcare professionals are essential for tackling the burgeoning problem of VBDs in India.
1.
"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.
2.
Recently released national data on drug use and abuse among Americans.
3.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Personalized Tumor Ecological Landscapes in Oncology
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Preserving Social Identity During Cancer Survivorship
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Regenerative Models of Tumor Microenvironments: Clinical Relevance and Emerging Insights
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
From Guidelines to Practice: Hematology
5.
Breast Cancer Awareness and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation